Federal contract award
W81K0024P0242
LYPHOCHEK WHOLE BLOOD METALS CONTROL - QUALITY CONTROL REAGENTS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRC0 WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $546.3K |
| Current contract value | $546.3K |
| Potential contract value / ceiling | $1.4M |
| Start date | Oct 1, 2024 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2029 |
| Latest award activity | Jan 7, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 9, 2026 | P00006 | $0 | PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT, W81K00-24-P-0242 WITH BIORAD LABORATORIES, INC., IS HEREBY EXTENDED FOR THE PERIOD 01 OCTOBER 2026 - 30 SEPTEMBER 2027 (OPTION YEAR 2). |
| Jan 7, 2026 | P00005 | $269.0K | FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR W81K00-24-P-0242 AND REMOVE SUB-CLINS 1005AC. 2005AC, 3005AC AND 4005AC FOR THE UNITY REAL TIME ADDITIONAL DATABASE. |
| Sep 18, 2025 | P00004 | $0 | PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT, W81K00-24-P-0242 WITH BIORAD LABORATORIES, INC., IS HEREBY EXTENDED FOR THE PERIOD 01 OCTOBER 2025 - 30 SEPTEMBER 2026 (OPTION YEAR 1). |
| Sep 17, 2025 | P00003 | $136.4K | INCREASE QUANTITY AND ADD NEW REAGENTS. |
| Aug 19, 2025 | P00002 | $-138.1K | DECREASE QUANTITIES OF REAGENTS. |
| Dec 5, 2024 | P00001 | $279.0K | LYPHOCHEK WHOLE BLOOD METALS CONTROL LEV - FY25 FUNDING MODIFICATION |
| Sep 20, 2024 | 0 | $0 | LYPHOCHEK WHOLE BLOOD METALS CONTROL - QUALITY CONTROL REAGENTS |
Estimated positioning window
Sep 30, 2028 – Mar 30, 2029
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2029-09-30 (1064 days from calculation)
- +15 points
- 80 historical awards in this buyer and category group
- +15 points
- 7 recorded award transactions
- +10 points
- Latest award action: 2026-01-07
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.